| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Sep 12, 2025 | Sep 16, 2025 | ZEVRA THERAPEUTICS, INC. | Director | Buy | 91.3 | +3,175 | 441.59% | ✗ | $24.7K |
| Mar 17, 2023 | Mar 21, 2023 | ZEVRA THERAPEUTICS, INC. | Director | Buy | 90.0 | +519 | 259.50% | ✗ | $2.5K |
| May 20, 2022 | May 24, 2022 | ZEVRA THERAPEUTICS, INC. | Director | Buy | 90.0 | +200 | 100.00% | ✗ | $974 |
| Oct 31, 2016 | Nov 2, 2016 | Viridian Therapeutics, Inc.\DE | CFO | Sell | 46.3 | -66,547 | -29.57% | ✗ | $24K |
| Aug 8, 2016 | Aug 10, 2016 | Viridian Therapeutics, Inc.\DE | CFO | Sell | 47.5 | -10,484 | -27.97% | ✗ | $5.1K |
| Aug 4, 2015 | Aug 5, 2015 | Viridian Therapeutics, Inc.\DE | CFO | Sell | 46.3 | -8,522 | -37.05% | ✗ | $13.3K |